Trials / Completed
CompletedNCT00606827
Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy
Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy in Patients Undergoing Coronary Angiography
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Ospedale Misericordia e Dolce · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Contrast-induced nephrophaty (CIN) accounts for more than 10% of hospital-acquired renal failure. Hydration with sodium bicarbonate is more protective than isotonic saline in animals. Limited data are available in humans. We compared the efficacy of sodium bicarbonate versus isotonic saline to prevent CIN in a large population of patients with renal dysfunction undergoing coronary angiography or intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium Bicarbonate | Patients in the sodium bicarbonate group (154 mEq/L) received 3 ml/kg for 1 hour before contrast medium, followed by an infusion of 1 ml/kg/h for 6 hours after the procedure |
| DRUG | Isotonic Saline | Patients assigned to the isotonic saline group received 1 ml/kg/h 0.9% sodium chloride for 12 hours before and after the procedure |
Timeline
- Start date
- 2005-01-01
- Completion
- 2006-03-01
- First posted
- 2008-02-05
- Last updated
- 2012-05-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00606827. Inclusion in this directory is not an endorsement.